Clinical outcomes of free gingival graft, xenogeneic collagen matrix, and acellular dermal matrix for peri-implant keratinized mucosa augmentation: a randomized controlled trial
Clinical Oral Investigations · 16.07.2026 · 30 (8)
DOI: 10.1007/s00784-026-07028-x ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Investigations, online erschienen am 16.07.2026. Verfasst von Shaoqing Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Implantology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Di…. Hauptthemen laut MEDLINE: Acellular Dermis, Collagen, Gingiva, Dental Implants. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Clinical Research Center of Shandong University, Natural Science Foundation of Shandong Province, cientific Research Fund of Hospital of Stomatology, Shandong University.
Abstract (Originalsprache)
OBJECTIVES: To evaluate the effects of autologous free gingival graft (FGG), xenogeneic collagen matrix (XCM), and acellular dermal matrix (ADM) combined with apically positioned flap (APF) on buccal soft-tissue volume change and keratinized mucosa augmentation around dental implants. MATERIALS AND METHODS: Forty-four implants with buccal keratinized mucosa width (KMW) 0.05). CONCLUSIONS: FGG plus APF provided the most favorable maintenance of peri-implant buccal soft-tissue volume and thickness over 12 months. XCM showed intermediate performance, whereas ADM showed the greatest dimensional reduction. All three grafts showed stable peri-implant clinical parameters over 12 months, achieved acceptable esthetic outcomes, and yielded high patient satisfaction. CLINICAL RELEVANCE: For peri-implant soft-tissue augmentation with APF, FGG showed better maintenance of buccal soft-tissue volume and thickness than ADM over 12 months, while XCM showed intermediate performance. Graft selection should therefore consider the expected need for long-term dimensional stability. TRIAL REGISTRATION: This trial was registered in the Chinese Clinical Trial Registry with the registration number ChiCTR2100041688 ( https://www.chictr.org.cn/showproj.html?proj=66722 ) on January 1, 2021.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Implantology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Diseases & Shandong Engineering Research Center of Dental Materials and…
Förderung
- Clinical Research Center of Shandong University
- Natural Science Foundation of Shandong Province
- cientific Research Fund of Hospital of Stomatology, Shandong University
Zitieren
APA
Sun, S., Zhao, W., Zhang, Y., Gong, Z., Dai, X., Zhang, S., Hao, Z., & Wen, Y. (2026). Clinical outcomes of free gingival graft, xenogeneic collagen matrix, and acellular dermal matrix for peri-implant keratinized mucosa augmentation: a randomized controlled trial. Clinical Oral Investigations, 30(8). https://doi.org/10.1007/s00784-026-07028-x
Vancouver
Sun S, Zhao W, Zhang Y, Gong Z, Dai X, Zhang S, et al. Clinical outcomes of free gingival graft, xenogeneic collagen matrix, and acellular dermal matrix for peri-implant keratinized mucosa augmentation: a randomized controlled trial. Clinical Oral Investigations. 2026;30(8). doi:10.1007/s00784-026-07028-x
BibTeX
@article{Sun2026,
author = {Sun, Shaoqing and Zhao, Wenxi and Zhang, Yunqiu and Gong, Zikai and Dai, Xingfang and Zhang, Shengjia and Hao, Zhenghao and Wen, Yong},
title = {Clinical outcomes of free gingival graft, xenogeneic collagen matrix, and acellular dermal matrix for peri-implant keratinized mucosa augmentation: a randomized controlled trial},
journal = {Clinical Oral Investigations},
year = {2026},
volume = {30},
number = {8},
doi = {10.1007/s00784-026-07028-x}
}
EUVIMED